REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Indonesia Pharma and Healthcare Sector Report 2021-2022

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: March 2021
Pages: 80
Available in: English

Indonesia’s pharmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indonesian government has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, Indonesia still has a gaping deficit in hospital beds, qualified medical workers, and intensive care facilities to deal with Southeast Asia’s most severe COVID-19 outbreak. Indonesia has a dual public-private healthcare system in which private healthcare providers play a crucial role, especially in delivering tertiary and specialist care. Responsibility for providing taxpayer-funded healthcare has primarily been devolved to provincial governments in Indonesia while the central government operates a limited number of multi-specialist hospitals.

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Indonesia . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Indonesia
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Indonesia
  • Crystallise the forces both driving and restraining this sector in Indonesia
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Indonesia
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).

 

See below for a complete table of report contents:

Indonesia Pharma and Healthcare Sector Report 2021-2022 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Indonesia Pharma and Healthcare Sector Report 2021-2022 -  Page 3
Indonesia Pharma and Healthcare Sector Report 2021-2022 -  Page 4
Indonesia Pharma and Healthcare Sector Report 2021-2022 -  Page 18
Indonesia Pharma and Healthcare Sector Report 2021-2022 -  Page 19
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?